Sarcoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sarcoma stocks.

Sarcoma Stocks Recent News

Date Stock Title
May 10 INBX Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
May 10 LGND Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
May 10 LGND Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
May 10 LGND Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
May 10 LGND Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
May 10 IMMX Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation
May 10 LGND Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why
May 9 ONCT Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript
May 9 ONCT Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M
May 9 ONCT Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
May 9 LGND Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
May 9 MNPR Monopar Therapeutics GAAP EPS of -$0.10
May 9 LGND CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
May 9 LGND Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
May 9 LGND Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
May 9 MNPR Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 9 LGND Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
May 8 ONCT Oncternal Therapeutics Q1 2024 Earnings Preview
May 8 PSTV Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
May 8 INBX Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
Sarcoma

A sarcoma is a cancer that arises from transformed cells of mesenchymal (connective tissue) origin. Thus, malignant tumors made of cancellous bone, cartilage, fat, muscle, vascular, or hematopoietic tissues are, by definition, considered sarcomas. This is in contrast to a malignant tumor originating from epithelial cells, which are termed carcinoma. Human sarcomas are quite rare. Common malignancies, such as breast, colon, and lung cancer, are almost always carcinoma. The term is from the Greek σάρξ sarx meaning "flesh".

Browse All Tags